Stock message boards
MNV
Market News Video
MNV MNV 10 Bargains You Can Buy Cheaper Than Insiders Did
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Short Interest In Cambrex Decreases By 25%
Wednesday, August 27, 3:40 PM ET, by Market News Video Staff

The most recent short interest data has been released by the NASDAQ for the 08/15/2014 ...

10.4% of XBI Holdings Seeing Recent Insider Buys
Friday, September 12, 9:41 AM ET, by Market News Video Staff

A look at the weighted underlying holdings of the SPDR S&P Biotech ETF (XBI) shows ...

AEGR: Insiders vs. Shorts
Tuesday, September 16, 2:35 PM ET, by Market News Video Staff

The most recent short interest data was recently released by the NASDAQ for the 08/29/2014 ...

Cambrex is Now Oversold (CBM)
Monday, September 22, 2:35 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Cambrex Enters Oversold Territory (CBM)
Tuesday, October 14, 4:30 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

  More articles:  1 2 3 4 5 6 7 next »

CBM Crosses Below Key Moving Average Level

By Market News Video Staff, Friday, October 7, 4:01 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Friday, shares of Cambrex Corp (NYSE:CBM) crossed below their 200 day moving average of $4.94, changing hands as low as $4.89 per share. Cambrex Corp shares are currently trading off about 6.3% on the day. The chart below shows the one year performance of CBM shares, versus its 200 day moving average:

Cambrex Corp 200 Day Moving Average Chart

Looking at the chart above, CBM's low point in its 52 week range is $3.87 per share, with $6.78 as the 52 week high point that compares with a last trade of $5.00.

CBM makes up 1.01% of the First Trust Small Cap Value AlphaDEX Fund ETF (AMEX:FYT)

CBM operates in the Drugs & Pharmaceuticals sector, among companies like Grupo Casa Saba, S.A. de C.V. (SAB) which is down about 9.3% today, and Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) trading lower by about 2.4%. Below is a three month price history chart comparing the stock performance of CBM, versus SAB and AEGR.

CBM,SAB,AEGR Relative Performance Chart


Free Trial: ''ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO''

The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   AEGR   Average   Below   Call   Cambrex   Corp   Crossing   Definition   Friday   Fund   Growth   Looking   NYSE   Pharmaceuticals   Price   Rate   Short   Stocks   Trial   Trust   Value   about   asset   average   below   changing   chart   designed   follow   history   last   makes   month   moving   performance   point   portfolio   program   raquo   regions   share   shares   slideshow   today   trading   versus   week   wherever   which   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

CBM Crosses Below Key Moving Average Level | Market News Video | Copyright © 2008 - 2015, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.